{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:06:26Z","timestamp":1790251586900,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Reports"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.stemcr.2020.11.001","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T13:27:15Z","timestamp":1607002035000},"page":"10-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Genomic Safe Harbor Expression of PAX7 for the Generation of Engraftable Myogenic Progenitors"],"prefix":"10.1016","volume":"16","author":[{"given":"Hyunkee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Azzag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayardo I.","family":"Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita C.R.","family":"Perlingeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stemcr.2020.11.001_bib1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.celrep.2013.02.012","article-title":"Epigenetic reprogramming of human embryonic stem cells into skeletal muscle cells and generation of contractile myospheres","volume":"3","author":"Albini","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.stemcr.2020.11.001_bib2","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/stem.1402","article-title":"A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation","volume":"31","author":"Arpke","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.stemcr.2020.11.001_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13395-020-00228-3","article-title":"Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I","volume":"10","author":"Azzag","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.stemcr.2020.11.001_bib4","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1533","article-title":"Derivation of engraftable skeletal myoblasts from human embryonic stem cells","volume":"13","author":"Barberi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.stemcr.2020.11.001_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0076-6879(00)27292-3","article-title":"Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances","volume":"327","author":"Baron","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.stemcr.2020.11.001_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/mt.2011.237","article-title":"Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector","volume":"20","author":"Bowles","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.stemcr.2020.11.001_bib7","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/nprot.2016.110","article-title":"Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in\u00a0vitro","volume":"11","author":"Chal","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stemcr.2020.11.001_bib8","doi-asserted-by":"crossref","first-page":"e4475","DOI":"10.1371\/journal.pone.0004475","article-title":"Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation","volume":"4","author":"Collins","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.stemcr.2020.11.001_bib9","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","article-title":"AAV-based gene therapies for the muscular dystrophies","volume":"28","author":"Crudele","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.stemcr.2020.11.001_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/stem.625","article-title":"Assessment of the myogenic stem cell compartment following transplantation of Pax3\/Pax7-induced embryonic stem cell-derived progenitors","volume":"29","author":"Darabi","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.stemcr.2020.11.001_bib11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","article-title":"Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice","volume":"10","author":"Darabi","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2020.11.001_bib12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nbt.3513","article-title":"Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease","volume":"34","author":"De Ravin","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stemcr.2020.11.001_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.stemcr.2020.11.001_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fonc.2019.00297","article-title":"Gene therapy leaves a vicious cycle","volume":"9","author":"Goswami","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.stemcr.2020.11.001_bib15","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/mt.2012.188","article-title":"Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation","volume":"20","author":"Goudenege","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.stemcr.2020.11.001_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41556-017-0010-2","article-title":"ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs","volume":"20","author":"Hicks","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.stemcr.2020.11.001_bib17","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1073\/pnas.1808303116","article-title":"Pluripotent stem cell-derived myogenic progenitors remodel their molecular signature upon in\u00a0vivo engraftment","volume":"116","author":"Incitti","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.stemcr.2020.11.001_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.stemcr.2017.04.022","article-title":"Expansion and purification are critical for the therapeutic application of pluripotent stem cell-derived myogenic progenitors","volume":"9","author":"Kim","year":"2017","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.stemcr.2020.11.001_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.scr.2017.07.013","article-title":"Generation of skeletal myogenic progenitors from human pluripotent stem cells using non-viral delivery of minicircle DNA","volume":"23","author":"Kim","year":"2017","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.stemcr.2020.11.001_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13287-018-0839-8","article-title":"Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system","volume":"9","author":"Lyu","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.stemcr.2020.11.001_bib21","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.celrep.2017.06.005","article-title":"PAX7 targets, CD54, integrin alpha9beta1, and SDC2, allow isolation of human ESC\/iPSC-derived myogenic progenitors","volume":"19","author":"Magli","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.stemcr.2020.11.001_bib22","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM199509283331303","article-title":"Myoblast transfer in the treatment of Duchenne's muscular dystrophy","volume":"333","author":"Mendell","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stemcr.2020.11.001_bib23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin immunity in Duchenne's muscular dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stemcr.2020.11.001_bib24","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1126\/science.1114758","article-title":"Direct isolation of satellite cells for skeletal muscle regeneration","volume":"309","author":"Montarras","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.stemcr.2020.11.001_bib25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/mt.2016.38","article-title":"Gene insertion into genomic safe harbors for human gene therapy","volume":"24","author":"Papapetrou","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.stemcr.2020.11.001_bib26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.stemcr.2017.02.016","article-title":"Inducible and deterministic forward programming of human pluripotent stem cells into neurons, skeletal myocytes, and oligodendrocytes","volume":"8","author":"Pawlowski","year":"2017","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.stemcr.2020.11.001_bib27","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.ymthe.2019.08.011","article-title":"Gene correction of LGMD2A patient-specific iPSCs for the development of targeted autologous cell therapy","volume":"27","author":"Selvaraj","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.stemcr.2020.11.001_bib28","doi-asserted-by":"crossref","first-page":"e47970","DOI":"10.7554\/eLife.47970","article-title":"Screening identifies small molecules that enhance the maturation of human pluripotent stem cell-derived myotubes","volume":"8","author":"Selvaraj","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.stemcr.2020.11.001_bib29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.stemcr.2014.07.001","article-title":"Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells","volume":"3","author":"Shelton","year":"2014","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.stemcr.2020.11.001_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1634\/stemcells.2007-0039","article-title":"Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration","volume":"26","author":"Smith","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.stemcr.2020.11.001_bib31","doi-asserted-by":"crossref","first-page":"140ra189","DOI":"10.1126\/scitranslmed.3003541","article-title":"Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy","volume":"4","author":"Tedesco","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.stemcr.2020.11.001_bib32","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.celrep.2018.10.067","article-title":"A myogenic double-reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors","volume":"25","author":"Wu","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.stemcr.2020.11.001_bib33","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.celrep.2017.01.040","article-title":"In\u00a0vivo human somitogenesis guides somite development from hPSCs","volume":"18","author":"Xi","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.stemcr.2020.11.001_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2020.11.001_bib35","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1182\/blood-2010-12-328161","article-title":"Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting","volume":"117","author":"Zou","year":"2011","journal-title":"Blood"}],"container-title":["Stem Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671120304495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671120304495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:46:42Z","timestamp":1761990402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213671120304495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2213671120304495"],"URL":"https:\/\/doi.org\/10.1016\/j.stemcr.2020.11.001","relation":{},"ISSN":["2213-6711"],"issn-type":[{"value":"2213-6711","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic Safe Harbor Expression of PAX7 for the Generation of Engraftable Myogenic Progenitors","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stemcr.2020.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}